Nyumbani › Alopecia Areata
Majaribio ya kliniki ya Alopecia Areata yanayovutia washiriki nchini Marekani
Masomo 17 ya Alopecia Areata yanavutia washiriki katika vituo vya Marekani nzima.
Miji yenye masomo mengi
- Indianapolis, INUtafiti 7
- San Antonio, TXUtafiti 6
- Miami, FLUtafiti 6
- Omaha, NEUtafiti 5
- New York City, NYUtafiti 4
- Irvine, CAUtafiti 3
- Troy, MIUtafiti 3
- Columbus, OHUtafiti 3
- Portland, ORUtafiti 3
- Houston, TXUtafiti 3
- Spokane, WAUtafiti 3
- Los Angeles, CAUtafiti 3
Kwa jimbo
- CaliforniaUtafiti 10
- FloridaUtafiti 8
- IllinoisUtafiti 3
- IndianaUtafiti 8
- MarylandUtafiti 5
- MassachusettsUtafiti 4
- MichiganUtafiti 5
- NebraskaUtafiti 5
- New YorkUtafiti 6
- North CarolinaUtafiti 3
- OhioUtafiti 6
- OregonUtafiti 3
- PennsylvaniaUtafiti 3
- South CarolinaUtafiti 3
- TexasUtafiti 7
- WashingtonUtafiti 4
Masomo yaliyosasishwa hivi karibuni
Maandishi rasmi ya utafiti (Kiingereza)
A Study to Evaluate the Safety and Effectiveness of Upadacitinib in Pediatric Participants With Alopecia Areata
InaajiriHatua 3
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT07772492A Study of LY4005130 in Adult Participants With Severe Alopecia Areata (Hair Loss)
InaajiriHatua 2
Umri 18 hadi 50 · Jinsia zote · Imesasishwa 22 Sep 2026 · NCT07533006A Study of 2 Doses of Ritlecitinib in People 12 Years of Age and Older With Alopecia Areata
InaajiriHatua 3
Umri 12 na zaidi · Jinsia zote · Imesasishwa 18 Sep 2026 · NCT06873945HCW9302 (Interleukin-2 Fusion Protein) for Alopecia Areata
InaajiriHatua 1
Umri 18 hadi 70 · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT07049328A Study in Young People and Adults to Learn About the Medicine Ritlecitinib for Treatment of Patchy Hair Loss, Known by the Medical Term as Moderate Alopecia Areata
InaajiriHatua 3
Umri 12 na zaidi · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT07733765Dupilumab in the Treatment of Pediatric Alopecia Areata
InaajiriHatua 2
Umri 6 hadi 17 · Jinsia zote · Imesasishwa 2 Sep 2026 · NCT05866562CorEvitas International Adolescent Alopecia Areata (AA) Drug Safety and Effectiveness Registry
InaajiriUtafiti wa uchunguzi
Umri 12 hadi 17 · Jinsia zote · Imesasishwa 17 Ago 2026 · NCT06562270A Study to Evaluate the Safety and Effectiveness of Upadacitinib Tablets in Adult and Adolescent Participants With Severe Alopecia Areata
InaajiriHatua 3
Umri 12 hadi 63 · Jinsia zote · Imesasishwa 3 Ago 2026 · NCT06012240Evaluation of Microbiota Transplant Therapy in Patients With Alopecia Areata
InaajiriHatua 2
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 26 Jun 2026 · NCT06747611Evaluate the Efficacy and Safety of Ruxolitinib on Hair Regrowth in Patients With Autoimmune Polyendocrinopathy Candidiasis Ectodermal Dystrophy (APECED)-Associated Alopecia Areata
InaajiriHatua 2Wajitolea wenye afya wanakaribishwa
Umri 12 hadi 75 · Jinsia zote · Imesasishwa 22 Jun 2026 · NCT05398809Regeneron AA Multicenter (Dupilumab)
InaajiriHatua 2
Umri 18 na zaidi · Jinsia zote · Imesasishwa 17 Jun 2026 · NCT05551793A Study of LAD603 in Adults With Alopecia Areata
InaajiriHatua 2
Umri 18 hadi 65 · Jinsia zote · Imesasishwa 20 Mei 2026 · NCT07311564A Long-Term Study to Learn About The Study Medicine Called Ritlecitinib in Children With Severe Alopecia Areata.
InaajiriHatua 3
Umri 6 hadi 14 · Jinsia zote · Imesasishwa 28 Apr 2026 · NCT07029828A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution in Subjects With Alopecia Areata
InaajiriHatua 1/2
Umri 18 hadi 55 · Jinsia zote · Imesasishwa 4 Mac 2026 · NCT06826196CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 9 Feb 2026 · NCT05745389Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down Syndrome
InaajiriHatua 2
Umri 12 na zaidi · Jinsia zote · Imesasishwa 2 Feb 2026 · NCT07242638Study to Evaluate the Efficacy and Safety of Deuruxolitinib in Adolescents With Severe Alopecia Areata
InaajiriHatua 3
Umri 12 hadi 17 · Jinsia zote · Imesasishwa 28 Jan 2026 · NCT07133308Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.